caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1619032224

Dora HoMD

Infectious DiseaseStanford, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Dora Ho's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 20 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Ann Leung
Diagnostic Radiology · Stanford, CA
41214
JEFFREY, ROBERT2595
GAYER, GABRIELA22112
Ingela Schnittger
Cardiology · Stanford, CA
2076
Andreas Loening
Diagnostic Radiology · Stanford, CA
1883
DESSER, TERRY1787
Linda Morimoto
Diagnostic Radiology · Stanford, CA
1678
Ranjan Ray
Advanced Heart Failure and Transplant Cardiology · San Francisco, CA
15111
Aruna Subramanian
Infectious Disease · Stanford, CA
15276
FEDERLE, MICHAEL1366
NPI 107360044113215
Karen Friday
Cardiology · Stanford, CA
1366
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
264
Unique beneficiaries
—
Total services
507
Distinct HCPCS
6
Medicare payment
$64K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 583 Infectious Disease providers in CA — below median (cohort median 564).
PRESCRIBING · PART D · 2024
Total Rx claims
202
Beneficiaries
—
Total drug cost
$357K
Distinct drugs
10
Brand share
41.6%
Top prescribed drugs
Aztreonam54 claims
Isavuconazonium Sulfate25 claims
Sulfamethoxazole/Trimethoprim23 claims
Acyclovir18 claims
Isoniazid17 claims
QUALITY · MIPS · 2024
Final MIPS score
88.5
Quality
87.1
Cost
69.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.57%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$18
Payment records
1
By payment type
Education$18